The driving force behind our company’s creation was a father’s determination to free his son from the burden of multiple daily insulin injections. Over years of technological advances, we developed Omnipod®, a line of tubeless, wearable, Pod-based insulin management systems.
in MedTech’s 2023 list of world’s largest MedTech companies
favorite insulin pump, 2023 Patient Choice Award winner
Omnipod by Insulet
Omnipod provides continuous insulin delivery through a wearable, tubeless, waterproof* insulin pump called a Pod, with no multiple daily injections. These simple, connected devices offer unprecedented freedom to people living with diabetes around the world.
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
Insulet (NASDAQ: PODD), headquartered in Acton, Massachusetts, and with offices and manufacturing facilities around the world, is a global company with growing reach. We strive to bring our innovations to all who need them, wherever they are.
We never stop pushing to make our revolutionary technologies even better for our customers. Our industry-leading research and development process is continuously striving to eliminate the complexities of diabetes management.
Our worldwide footprint brings a responsibility to treat all people, and the planet, with care. By focusing on environmental sustainability, we demonstrate our support for the global community at large.